logo

Targeted Therapy for Non-Small Cell Lung Cancer: Mechanisms of Resistance

Explain the mechanisms by which resistance develops in a targeted therapy used in metastatic NSCLC.

5 Pages541 Words431 Views
   

Added on  2023-06-15

About This Document

This article discusses targeted therapy for non-small cell lung cancer, including the use of epidermal growth factor receptor inhibitors and their side effects. It also explores the mechanisms of resistance to targeted therapy.

Targeted Therapy for Non-Small Cell Lung Cancer: Mechanisms of Resistance

Explain the mechanisms by which resistance develops in a targeted therapy used in metastatic NSCLC.

   Added on 2023-06-15

ShareRelated Documents
Target therapy
Targeted Therapy for Non-Small Cell Lung Cancer: Mechanisms of Resistance_1
Table of Contents
TITLE..............................................................................................................................................1
EXPLANATION.............................................................................................................................1
REFERENCES................................................................................................................................2
Targeted Therapy for Non-Small Cell Lung Cancer: Mechanisms of Resistance_2

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
EGFR - Epidermal growth factor receptor
|8
|1786
|15

Journal of Thoracic Oncology
|11
|3117
|19

Test for Colon Cancer Assignment 2022
|6
|1242
|6

Medical Terminology: Chemotherapy, Palpitation, and Percussion
|3
|571
|190

Immunohistochemistry Predictive Markers Report
|5
|787
|20

The National Tobacco Campaign (National Tobacco Campaign) aims to reduce tobacco exposure for all Australians
|15
|4004
|391